Viral Gastroenteritis Prevalence in Iranian Pediatric Population: A Systematic Review
Abstract
Background: Viral gastroenteritis infection, a prevalent condition in adolescents and children, is still a rigid and serious problem among humans. This disease is responsible for up to three million fatalities nationwide. noroviruses, rotaviruses, astroviruses, adenoviruses, and sapoviruses are the most common and well-known pathogens associated with viral gastroenteritis agents. In this systematic review, we extracted all original articles and data on viral gastroenteritis that were performed on the Iranian pediatric population. Methods: To investigate the viral agent pathogens of gastroenteritis in Iran, 48 articles on the identification of viral gastroenteritis were gathered from the existing data. Viral gastroenteritis was detected in fourteen provinces, including the southern and northern parts of Iran. The seasonal distribution in Iran was analyzed as well. Finally, all the data from 1978-2021, along with their detailed information, were summarized, including the number of patients, the number of positive cases, applied technics, and the region of the studied cases in Iran. Results: Based on the results, most of the viral detection was associated with Rotavirus, the major pathogen responsible for gastroenteritis disease, followed by Adenovirus, Norovirus, Parechovirus, Bocavirus, Astrovirus, Aichivirus, Sapovirus, and three case reports of SARS-CoV-2 that were associated with viral gastroenteritis. Conclusion: Different studies conducted over Iran, including the…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations
- Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
- Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial
- Gastrointestinal manifestations in COVID-19
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
- Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.